Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
about
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combinationSelective oestrogen receptor modulators decrease the inflammatory response of glial cells.Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.Prevention of diseases after menopause.An overview of early drug development for endometriosis.Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
P2860
Q35092811-FEDE1228-F61C-43B0-95DE-A47521C0F063Q37095740-128775AC-6784-497A-9C66-AEBAE938094FQ37874684-F8DE3BFD-044C-4A58-96D2-4793E96CA302Q38106748-FD839D4F-B7A9-4F1F-90CA-E32E88F1889EQ38223587-6598BAFC-E294-4943-9F3A-252FEAEBA501Q38653393-EB83910E-3BEC-4FA8-B542-CA74FFBF7478Q48671400-61737A62-3E09-4D7B-8443-A1A2F4924045
P2860
Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@en
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@nl
type
label
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@en
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@nl
prefLabel
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@en
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@nl
P2860
P1433
P1476
Bazedoxifene: a novel selectiv ...... r postmenopausal osteoporosis.
@en
P2093
T J de Villiers
P2860
P304
P356
10.3109/13697130903568542
P577
2010-06-01T00:00:00Z